FASCINATION ABOUT DILAUDID IN ITALIA

Hepatic Impairment Following oral administration of an individual four mg dose (2 mg hydromorphone speedy-release tablets), imply publicity to hydromorphone (Cmax and AUC∞) is improved four-fold in patients with moderate (Baby-Pugh Team B) hepatic impairment as opposed with subjects with standard hepatic purpose. As a consequence of enhanced publ